Log in to search using one of your social media accounts:

 

Baseball star returns after finishing cancer treatment
Colorado Rockie's pitcher Chad Bettis (pictured left playing and right during chemotherapy treatments) is returning to the major leagues after a nine month battle with testicular cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - August 14, 2017 Category: Consumer Health News Source Type: news

Cancer symptoms: Could YOU spot these three deadly forms only affecting men?
CANCER affects both men and women, but the former are more likely to suffer. Many types of the condition affect both genders, but there are three - prostate cancer, testicular cancer and penile cancer - that only develop in men. (Source: Daily Express - Health)
Source: Daily Express - Health - August 5, 2017 Category: Consumer Health News Source Type: news

Interval Training Cuts CVD Risk in Testicular Cancer Survivors
High - intensity aerobic interval training improves cardiorespiratory fitness compared with usual care (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 29, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Internal Medicine, Oncology, Pulmonology, Urology, Journal, Source Type: news

On Baseball: Fatherhood, and Illness, Retools the Priorities of Rockies Starter Chad Bettis
Bettis, 28, who was battling testicular cancer when his baby daughter, Everleigh, arrived, said, “ I kind of found out where baseball stood. ” (Source: NYT Health)
Source: NYT Health - July 22, 2017 Category: Consumer Health News Authors: TYLER KEPNER Tags: Baseball Testicular Cancer Pregnancy and Childbirth Chemotherapy Colorado Rockies Bettis, Chad (1989- ) Source Type: news

Cancer survival in England: adult, stage at diagnosis and childhood patients followed up to 2016
This statistical bulletin Among 25 cancers forming National Statistics, 1-year survival was highest for skin melanoma (>97%) and 5-year survival was highest for testicular cancer (95.9%) and skin melanoma in women (93.9%). Pancreatic cancer had lowest 1-year survival for men (22.9%) and women (24.7%). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 30, 2017 Category: Consumer Health News Source Type: news

Why Fertility Treatments Are So Out Of Reach For Most Americans
Much has been made of the high cost of rearing children in the United States, and rightly so. Families spend more than $230,000 on average to raise kids from birth to age 17 — a figure that doesn’t include the cost of college.  But for the 6.9 million women who have turned to fertility services, the bills pile up well before they ever hold a baby in their arms. A single cycle of in vitro fertilization, or IVF, costs more than $12,000 on average in the United States, not counting the cost of medications and travel. Only 15 states require insurance coverage for fertility treatments. So for man...
Source: Healthy Living - The Huffington Post - June 21, 2017 Category: Consumer Health News Source Type: news

Lab notes: a quantum leap and life on Mars – the week science went sci-fi
The sensible thing to do is calm down, figure out how to take care of planet Earth and all be a bit better about not making ourselves extinct. But who cares about sensible: Elon Musk has revealed the details (well, let ’s call them that) of hiscolonisation vision for Mars, including an “intentionally fuzzy” 10-year timeframe for flights. So once you’ve got yourself all signed up, to prepare for the trip you’ll need a tan, right? You’ll be a long way from any salons, and indeed the sun, so what about using anewly-created tanning chemical? It causes the release of dark pigment in skin, cre...
Source: Guardian Unlimited Science - June 16, 2017 Category: Science Authors: Tash Reith-Banks Tags: Science Source Type: news

Nonpalpable Intratesticular Mass in a Young Man With a History of Contralateral Retractile Testis
A 24-year-old otherwise healthy man with a history of retractile right testicle managed with right orchidopexy at age 9 presented with a several weeks ’ history of discomfort in the left testicle. He has no family history of testicular cancer. (Source: CancerNetwork)
Source: CancerNetwork - June 15, 2017 Category: Cancer & Oncology Authors: J. Ryan Mark, MD Leonard G. Gomella, MD Tags: Case Studies Oncology Journal Source Type: news

Testicular cancer symptoms: Simple test could predict risk of 'young man's' disease
TESTICULAR cancer - also known as cancer of the testicle - is one of the less common cancers and tends to mostly affect men between 15 and 49 years of age. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2017 Category: Consumer Health News Source Type: news

Testicular cancer symptoms - THIS simple test could predict risk of disease
TESTICULAR cancer - also known as cancer of the testicle - is one of the less common cancers and tends to mostly affect men between 15 and 49 years of age. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2017 Category: Consumer Health News Source Type: news

International study identifies new genetic risk factors for testicular cancer
(H. Lee Moffitt Cancer Center& Research Institute) Moffitt researcherslaunched a large analysis of five major testicular cancer studies to investigate genetic risk factors linked to TGCT. Their results, which uncovered eight new genetic markers associated with TGCT, were published in the June 12 issue of Nature Genetics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 13, 2017 Category: Cancer & Oncology Source Type: news

Study uncovers new insight on inherited testicular cancer risk
An analysis of five major studies has identified new genetic locations that may cause men to have the highest risk of developing testicular cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 12, 2017 Category: Consumer Health News Source Type: news

Testicular cancer: men most at risk could be identified using new gene group
Discovery of 19 new genes could allow doctors to spot the 1% of men most at risk of the cancer, allowing closer monitoring or preventative treatmentResearchers believe they can identify the 1% of men who are most at risk from testicular cancer after they discovered a new group of genes linked to the disease.Screening men for the 19 new genes, along with 25 known already, would allow doctors to spot those who are 14 times more likely than usual to develop the cancer, the scientists said.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 12, 2017 Category: Science Authors: Ian Sample Science editor Tags: Cancer research Testicular cancer Men's health Science & wellbeing Medical research Genetics Society Source Type: news

Medical News Today: Testicular cancer: Genetic test steps closer
A genetic test that predicts testicular cancer in healthy men steps closer as scientists discover 19 more DNA markers that raise risk of disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 12, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Study sheds new light on inherited testicular cancer risk
(University of Pennsylvania School of Medicine) An analysis of data from five major studies of testicular cancer has identified new genetic locations that could be susceptible to inherited testicular germ cell tumors. The findings, which researchers call a success story for genome mapping, could help doctors understand which men are at the highest risk of developing the disease and signal them to screen those patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2017 Category: Cancer & Oncology Source Type: news

Genetic testing can pick out men at increased risk of testicular cancer
(Institute of Cancer Research) Testing for large numbers of genetic changes can identify men with over a 10-fold increased risk of testicular cancer, a new study shows.Researchers found that testing for newly identified genetic factors along with others found in their previous studies could pick out men at increased risk, who might potentially benefit from monitoring or preventative treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2017 Category: Cancer & Oncology Source Type: news

Testicular cancer symptoms: Do YOU know the three factors that can up your risk?
TESTICULAR cancer is one of the less common cancers, and it tends to affect younger men between 15 and 49. However, there are factors which may increase your risk of developing symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - June 5, 2017 Category: Consumer Health News Source Type: news

Hypogonadism Common in Testicular Cancer Survivors Hypogonadism Common in Testicular Cancer Survivors
Survivors of testicular cancer are at risk for low testosterone, which in turn puts them at risk for a wide range of chronic health problems.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 2, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Many Testicular Cancer Survivors May Have Undiagnosed Hypogonadism
A new study is suggesting that a high percentage of testicular cancer survivors may suffer from hypogonadism. (Source: CancerNetwork)
Source: CancerNetwork - June 2, 2017 Category: Cancer & Oncology Authors: John Schieszer Tags: Conferences/ASCO News Testicular Cancer Source Type: news

First-ever global study finds massive health care inequity
A first-ever global study finds massive inequity of access to and quality of health care among and within countries, and concludes people are dying from causes with well-known treatments. For example, on a scale of 1 to 100 for health care access and quality, Norway and Australia each scored 90 overall, among the highest in the world. However, Norway scored 65 in its treatment for testicular cancer, and Australia scored 52 for treating non-melanoma skin cancer. (Source: World Pharma News)
Source: World Pharma News - May 18, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Male infertility could raise the risk of testicular cancer
Researchers from Lund University in Sweden found infertile men are likely to suffer from a deficiency of the hormone testosterone. This may increase the risk of testicular cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - May 17, 2017 Category: Consumer Health News Source Type: news

Testicular cancer signs: Do you know THESE symptoms?
TESTICULAR cancer mainly affects younger men between the age of 15 and 49, and if caught early, has a survival rate of 99 per cent. These are the common symptoms to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - May 14, 2017 Category: Consumer Health News Source Type: news

Testicular cancer symptoms: Do you know THESE signs?
TESTICULAR cancer mainly affects younger men between the age of 15 and 49, and if caught early, has a survival rate of 99 per cent. These are the common symptoms to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - May 13, 2017 Category: Consumer Health News Source Type: news

Medicaid expansion hangs in balance as lawmakers tackle $1.6B deficit
Matthew Loucks of Boring, Oregon put off obtaining a diagnosis for his testicular cancer until he couldn ’t walk because he couldn’t afford his insurance deductible. The delay meant Loucks had to undergo multiple surgeries to remove the tumors. He developed thyroid cancer, along with a disease that left him legally blind in one eye. Faced with $130,000 in medical bills he couldn’t afford, Loucks lost his home and declared bankruptcy. As if that wasn’t enough hardship, the father of four… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 11, 2017 Category: American Health Authors: Elizabeth Hayes Source Type: news

Testicular cancer symptoms: Would YOU recognise these six signs?
TESTICULAR cancer accounts for less than one per cent of all cancer cases in the UK, but levels have increased by 28 per cent since the 1990s despite a umber of treatment options. These are the signs and symptoms to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - May 3, 2017 Category: Consumer Health News Source Type: news

And On His 92nd Day, He Fired The Surgeon General
If you saw the “Diabetic Lesbians and a Blushing Bride” episode of last season’s CBS sitcom “Mom,” an improbably funny series about the struggles of a mother (Allison Janney) and daughter (Anna Farris) in recovery from alcohol and drug abuse, the last five minutes held a shocker for you: a teenager played by recurring guest star Emily Osment dies of a drug overdose. But then you were in for another surprise: U.S. Surgeon General Vivek Murthy in dress blues, flanked by Janney and Farris, warning that drug overdoses kill more Americans than car crashes. The families behind these numbers, he...
Source: Healthy Living - The Huffington Post - April 24, 2017 Category: Consumer Health News Source Type: news

'Thousands of people read about my testicular cancer'
After Andrew Lowden's blog was shared widely, he launched #testicletuesday to raise awareness. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 21, 2017 Category: Consumer Health News Source Type: news

Higher Cancer Deaths in Patients With Learning Difficulties Higher Cancer Deaths in Patients With Learning Difficulties
The cancer-specific mortality rate was four-fold higher in patients with testicular cancer who also had learning difficulties than in those without.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Men with learning difficulties four times more likely to die of testicular cancer
People with learning difficulties are 4 times more likely to die of testicular cancer than the general population. This is the first work relating cancer deaths to learning difficulties, with researchers now testing if this finding applies to all cancers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news

Several Actionable Targets Identified in Testicular Cancer
This video highlights recent research in cisplatin-resistant testicular cancer, including a study on whole exome sequencing that revealed several actionable targets. (Source: CancerNetwork)
Source: CancerNetwork - March 27, 2017 Category: Cancer & Oncology Authors: Aditya Bagrodia, MD Tags: Videos Genitourinary Cancers Source Type: news

Reduced, Compressed Chemotherapy Fails in Pediatric Germ Cell Tumors
Event-free survival was not maintained in children and adolescents with intermediate-risk malignant germ cell tumors when cisplatin-based chemotherapy was reduced from four to three cycles and compressed from 5 to 3 days per cycles. (Source: CancerNetwork)
Source: CancerNetwork - March 11, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Genitourinary Cancers Gynecologic Cancers News Ovarian Cancer Pediatric Cancers Testicular Cancer Source Type: news

Single-Cycle of BEP Shows Promise Against Testicular Cancer Recurrence
A single cycle of adjuvant bleomycin, etoposide, and cisplatin (BEP) chemotherapy might reduce recurrence rates for nonseminomatous or combined germ cell tumors of the testis. (Source: CancerNetwork)
Source: CancerNetwork - February 18, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: ASCO Genitourinary Cancers Symposium News Testicular Cancer Source Type: news

Drug used to combat pain medication side effects may help with gastrointestinal recovery
A drug given to reduce the side effects of strong post-surgery pain medications resulting in a reduced length of hospital stay for patients who have undergone major gastrointestinal or bladder cancer procedures is found to have similar benefit for some patients undergoing surgery for testicular cancer. An investigator explored the impact of alvimopan in those patients who underwent RPLND. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 14, 2017 Category: Science Source Type: news

Testicular cancer symptom: THIS is the best time of day to check your testicles for lumps
TESTICULAR cancer is the most common cancer for men aged between 15 and 45, and This Morning explained which symptoms to look for to diagnose the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - February 10, 2017 Category: Consumer Health News Source Type: news

Extensive use of fluorinated chemicals in fast food wrappers: Chemicals can leach into food
Previous studies have linked the chemicals to kidney and testicular cancers, thyroid disease, low birth weight and immunotoxicity in children, among other health issues. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 1, 2017 Category: Science Source Type: news

Late Metabolic Effects Common in Testicular Cancer Survivors Late Metabolic Effects Common in Testicular Cancer Survivors
Testicular cancer survivors treated with platinum-based chemotherapy face a 20% risk of developing metabolic syndrome.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Jury orders DuPont to pay $10.5 million over leaked chemical
(Reuters) - A U.S. jury in Ohio ordered DuPont on Thursday to pay $10.5 million in punitive damages to a man who said he developed testicular cancer from exposure to a toxic chemical leaked from a Dupont plant, the plaintiff's lawyer Robert Bilott said. (Source: Reuters: Health)
Source: Reuters: Health - January 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Cancer Facts and Figures: Death Rate Down 25% Since 1991
By Stacy Simon The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society. The cancer death rate for men and women combined fell 25% from its peak in 1991 to 2014, the most recent year for which data are available. This decline translates to more than 2.1 million deaths averted during this time period. “Cancer Statistics, 2017,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the US this year. The estimat...
Source: American Cancer Society :: News and Features - January 5, 2017 Category: Cancer & Oncology Tags: General Information Source Type: news

Guys, Taboo of the Black Eyed Peas wants you to man up and get a cancer check
Guys: Jimmy Luis Gomez, a.k.a. Taboo of the multiple Grammy-winning pop band the Black Eyed Peas, wants you to man up and talk with your doctor about getting your testicles regularly checked for cancer.“I was diagnosed with Stage 2 testicular cancer in 2014 after six years of chronic back pain,”... (Source: L.A. Times - Health)
Source: L.A. Times - Health - December 29, 2016 Category: Consumer Health News Authors: James Fell Source Type: news

New drug shows promise in shrinking testicular tumors
Amy WallaceBONN, Germany, Dec. 28 (UPI) -- Scientists have discovered a drug, originally developed as a male contraceptive, has the potential to treat testicular cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 28, 2016 Category: Consumer Health News Source Type: news

New pharmacon allows testicular tumors to shrink
A new active pharmaceutical ingredient may help against severe forms of testicular cancer, which only respond inadequately to other therapies. In mice, the substance kills degenerated cells and allows testicular tumors to shrink. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 28, 2016 Category: Science Source Type: news

New pharmacon allows testicular tumors to shrink
(University of Bonn) A new active pharmaceutical ingredient may help against severe forms of testicular cancer, which only respond inadequately to other therapies. In mice, the substance kills degenerated cells and allows testicular tumors to shrink. Researchers at the University of Bonn were able to demonstrate this in a recent study. However, first clinical trials are still pending. The work has now been published in the 'Journal of Cellular and Molecular Medicine'. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 28, 2016 Category: Global & Universal Source Type: news

DuPont Hit With $2 mln Verdict Over Teflon-Making Chemical DuPont Hit With $2 mln Verdict Over Teflon-Making Chemical
A U.S. jury in Ohio on Wednesday ordered DuPont to pay $2 million to a man who said he developed testicular cancer from exposure to a toxic chemical leaked from one of the company's plants, according to the plaintiff's lawyer Robert Bilott.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 23, 2016 Category: Pathology Tags: Public Health & Prevention News Source Type: news

10 Powerful Survivor Stories From 2016
In Stories of Hope, we regularly publish the stories of people who have a positive message to share, whether their cancer diagnosis was just recently, or long ago. Our featured survivors share words of inspiration, wisdom, hope, and support in these stories about how their lives have been changed by cancer. Our editors have chosen 10 of the most inspirational stories of 2016. For many who are facing a cancer diagnosis, or any other illness or hardship, hearing from others who've been through one already can be a great source of comfort and support. We hope you will find inspiration in these stories of cancer survivors. &nb...
Source: American Cancer Society :: News and Features - December 21, 2016 Category: Cancer & Oncology Tags: Coping with Cancer Source Type: news

A Promise Grows – Raising Funds and Awareness for Testicular Cancer
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - December 14, 2016 Category: Cancer & Oncology Source Type: news

Scientists identify unique genomic features in testicular cancer
Researchers have identified unique genomic changes that may be integral to testicular cancer development and explain why the great majority are highly curable with chemotherapy – unlike most solid tumors. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 1, 2016 Category: Science Source Type: news

Scientists identify unique genomic features in testicular cancer
(Dana-Farber Cancer Institute) Researchers led by scientists at Dana-Farber Cancer Institute say they have identified unique genomic changes that may be integral to testicular cancer development and explain why the great majority are highly curable with chemotherapy -- unlike most solid tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2016 Category: Cancer & Oncology Source Type: news

Testicular Cancer
Title: Testicular CancerCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/28/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 28, 2016 Category: Cancer & Oncology Source Type: news

Airman Reflects on His Battle with Testicular Cancer
Tech. Sgt. Nathan Combs tells of his fight with stage II non-seminoma, a cancer that affects the testicle but is curable in almost 90% of cases (Source: Disabled World)
Source: Disabled World - November 21, 2016 Category: Disability Tags: Your Disability Stories Source Type: news

DuPont: C8 Lawsuit Should Be Dismissed For Plaintiff's Lack Of Causation
COLUMBUS, Ohio - E.I. du Pont de Nemours and Co. on Oct. 24 filed a brief in Ohio federal court, arguing that one of the cases included in the multidistrict litigation regarding alleged injuries from exposure to perfluorooctanoic acid (known as C8) should be dismissed because the plaintiff cannot establish that C8 from DuPont's Washington Works facility was the proximate and specific cause of his testicular cancer (In re E.I. du Pont de Nemours and Co. C8 Personal Injury Litigation, MDL No. 2433, No. 13-2433, S.D. Ohio). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - November 1, 2016 Category: Medical Law Source Type: news